Literature DB >> 21879276

Long-term outcomes after resection versus transplantation for hepatocellular carcinoma within UCSF criteria.

Cheng-Maw Ho1, Po-Huang Lee, Chi-Ling Chen, Ming-Chih Ho, Yao-Ming Wu, Rey-Heng Hu.   

Abstract

PURPOSE: We compared the long-term outcomes of resection and transplantation for hepatocellular carcinoma (HCC) while satisfying the University of California at San Francisco criteria.
METHODS: HCC patients who underwent liver resection (n = 746) and transplantation (n = 54) between 2001 and 2007 were reviewed. Overall and disease-free survival rates were evaluated using the Kaplan-Meier estimator, and independent prognostic factors were determined using the Cox proportional regression model. The presence of cirrhosis was used to divide the patients into groups. The patients who received primary transplantation were further analyzed.
RESULTS: Nine years after surgery, the patients' overall survival was similar in the resection and transplantation groups (75.9 and 77.2%, respectively). Furthermore, the recurrence rate in the resection group was higher than that in the transplantation group (65 vs. 34.4%; adjusted hazard ratio, 3.27; range, 1.76-6.08), especially for cirrhosis patients (adjusted hazard ratio, 4.28; range, 2.14-8.56). The results suggested that noncirrhotic patients who underwent resection had a better survival advantage than primary liver transplant recipients did (adjusted hazard ratio, 0.46; range, 0.18-1.21). However, noncirrhotic patients had higher recurrence rates (59.2 vs. 15.8%; adjusted hazard ratio, 3.98; range, 1.26-12.58). Similar trends were noted in patients with hepatitis B virus infection and/or a single tumor.
CONCLUSIONS: Long-term survival rates after liver transplantation and resection were similar, but the latter was associated with a higher recurrence rate.

Entities:  

Mesh:

Year:  2011        PMID: 21879276     DOI: 10.1245/s10434-011-1975-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  18 in total

1.  Milan criteria, multi-nodularity, and microvascular invasion predict the recurrence patterns of hepatocellular carcinoma after resection.

Authors:  Hung-Hsu Hung; Hao-Jan Lei; Gar-Yang Chau; Chien-Wei Su; Cheng-Yuan Hsia; Wei-Yu Kao; Wing-Yiu Lui; Wen-Chieh Wu; Han-Chieh Lin; Jaw-Ching Wu
Journal:  J Gastrointest Surg       Date:  2012-12-06       Impact factor: 3.452

2.  Resection or Transplant in Early Hepatocellular Carcinoma.

Authors:  Markus B Schoenberg; Julian N Bucher; Adrian Vater; Alexandr V Bazhin; Jingcheng Hao; Markus O Guba; Martin K Angele; Jens Werner; Markus Rentsch
Journal:  Dtsch Arztebl Int       Date:  2017-08-07       Impact factor: 5.594

3.  Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma.

Authors:  Wen-Chao Zhao; Hai-Bin Zhang; Ning Yang; Yong Fu; Wei Qian; Ben-Dong Chen; Lu-Feng Fan; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2012-07-07       Impact factor: 5.742

4.  Patients with multiple hepatocellular carcinomas within the UCSF criteria have outcomes after curative resection similar to patients within the BCLC early-stage criteria.

Authors:  Wen-Chao Zhao; Ning Yang; Nan Zhu; Hai-Bin Zhang; Yong Fu; Hua-Bang Zhou; Wen-Ke Cai; Ben-Dong Chen; Guang-Shun Yang
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

Review 5.  Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun.

Authors:  Taizo Hibi; Osamu Itano; Masahiro Shinoda; Yuko Kitagawa
Journal:  Surg Today       Date:  2016-04-29       Impact factor: 2.549

Review 6.  Hepatocellular carcinoma and other malignancies in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2013-01-10       Impact factor: 3.199

Review 7.  Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine.

Authors:  Taizo Hibi; Masahiro Shinoda; Osamu Itano; Yuko Kitagawa
Journal:  Organogenesis       Date:  2014-05-16       Impact factor: 2.500

8.  Surgery for Intermediate and Advanced Hepatocellular Carcinoma: A Consensus Report from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).

Authors:  Ming-Chih Ho; Kiyoshi Hasegawa; Xiao-Ping Chen; Hiroaki Nagano; Young-Joo Lee; Gar-Yang Chau; Jian Zhou; Chih-Chi Wang; Young Rok Choi; Ronnie Tung-Ping Poon; Norihiro Kokudo
Journal:  Liver Cancer       Date:  2016-09-14       Impact factor: 11.740

9.  Long-term survival in patients with T2 hepatocellular carcinoma after primary curative resection can be further stratified by tumor size.

Authors:  Cheng-Maw Ho; Rey-Heng Hu; Po-Huang Lee; Yao-Ming Wu; Ming-Chih Ho
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

Review 10.  Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma.

Authors:  Po-Chih Yang; Cheng-Maw Ho; Rey-Heng Hu; Ming-Chih Ho; Yao-Ming Wu; Po-Huang Lee
Journal:  World J Hepatol       Date:  2016-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.